Ausiello Dennis A's Form 4 filing
Alnylam Pharmaceuticals, Inc. (ALNY) · filed Aug 15, 2025
- Accession no.
- 0001735276-25-000079
- Filed
- Aug 15, 2025
- Trade date
- Aug 14, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 17 non-derivative transactions and 6 derivative transactions. Open-market sales total $13.7M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ausiello Dennis ACIK 0001381994 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2025 | Common Stock | MOption exerciseAcquired | +9,000 | $72.01 | +$648,090 | 9,911 | Direct | |
| Aug 14, 2025 | Common Stock | MOption exerciseAcquired | +5,153 | $128.31 | +$661,181.43 | 15,064 | Direct | |
| Aug 14, 2025 | Common Stock | MOption exerciseAcquired | +4,581 | $148.77 | +$681,515.37 | 19,645 | Direct | |
| Aug 14, 2025 | Common Stock | MOption exerciseAcquired | +5,228 | $151.22 | +$790,578.16 | 24,873 | Direct | |
| Aug 14, 2025 | Common Stock | MOption exerciseAcquired | +4,032 | $171.95 | +$693,302.4 | 28,905 | Direct | |
| Aug 14, 2025 | Common Stock | MOption exerciseAcquired | +3,454 | $189.87 | +$655,810.98 | 32,359 | Direct | |
| Aug 14, 2025 | Common Stock | SSaleDisposed | −1,985 | $430.81 | −$855,157.85 | 30,374 | Direct | |
| Aug 14, 2025 | Common Stock | SSaleDisposed | −1,938 | $432.94 | −$839,037.72 | 28,436 | Direct | |
| Aug 14, 2025 | Common Stock | SSaleDisposed | −2,098 | $434.50 | −$911,581 | 26,338 | Direct | |
| Aug 14, 2025 | Common Stock | SSaleDisposed | −7,675 | $435.40 | −$3,341,695 | 18,663 | Direct | |
| Aug 14, 2025 | Common Stock | SSaleDisposed | −5,358 | $436.00 | −$2,336,088 | 13,305 | Direct | |
| Aug 14, 2025 | Common Stock | SSaleDisposed | −1,922 | $437.56 | −$840,990.32 | 11,383 | Direct | |
| Aug 14, 2025 | Common Stock | SSaleDisposed | −2,086 | $438.34 | −$914,377.24 | 9,297 | Direct | |
| Aug 14, 2025 | Common Stock | SSaleDisposed | −5,302 | $439.27 | −$2,329,009.54 | 3,995 | Direct | |
| Aug 14, 2025 | Common Stock | SSaleDisposed | −1,238 | $440.54 | −$545,388.52 | 2,757 | Direct | |
| Aug 14, 2025 | Common Stock | SSaleDisposed | −1,205 | $441.88 | −$532,465.4 | 1,552 | Direct | |
| Aug 14, 2025 | Common Stock | SSaleDisposed | −641 | $442.66 | −$283,745.06 | 911 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2025 | Common Stock | MOption exerciseDisposed | −9,000 | $0.00 | $0 | 0 | Direct | |
| Aug 14, 2025 | Common Stock | MOption exerciseDisposed | −5,153 | $0.00 | $0 | 0 | Direct | |
| Aug 14, 2025 | Common Stock | MOption exerciseDisposed | −4,581 | $0.00 | $0 | 0 | Direct | |
| Aug 14, 2025 | Common Stock | MOption exerciseDisposed | −5,228 | $0.00 | $0 | 0 | Direct | |
| Aug 14, 2025 | Common Stock | MOption exerciseDisposed | −4,032 | $0.00 | $0 | 0 | Direct | |
| Aug 14, 2025 | Common Stock | MOption exerciseDisposed | −3,454 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.